Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.91 $2.61 Thursday, 9th May 2024 CHRS stock ended at $2.12. This is 4.93% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 7.35% from a day low at $2.11 to a day high of $2.27.
90 days $1.91 $2.87
52 weeks $1.44 $5.91

Historical Coherus BioSciences prices

Date Open High Low Close Volume
May 31, 2016 $18.16 $19.18 $17.83 $18.65 716 031
May 27, 2016 $18.02 $18.27 $17.30 $17.96 355 449
May 26, 2016 $18.31 $18.59 $17.90 $18.01 219 146
May 25, 2016 $18.48 $18.57 $18.10 $18.26 271 375
May 24, 2016 $18.30 $18.55 $17.87 $18.28 358 972
May 23, 2016 $18.29 $18.96 $17.75 $18.12 951 565
May 20, 2016 $19.03 $19.52 $18.75 $19.50 167 437
May 19, 2016 $19.27 $19.30 $17.98 $18.96 432 571
May 18, 2016 $18.54 $19.88 $18.00 $19.49 1 701 325
May 17, 2016 $16.12 $20.01 $16.00 $18.85 1 631 606
May 16, 2016 $15.40 $16.30 $15.02 $16.27 380 878
May 13, 2016 $15.99 $16.13 $15.06 $15.23 227 780
May 12, 2016 $17.33 $17.33 $15.61 $16.02 295 152
May 11, 2016 $17.84 $18.65 $17.13 $17.17 202 635
May 10, 2016 $18.82 $19.17 $15.04 $18.00 1 206 288
May 09, 2016 $19.15 $19.74 $18.90 $19.20 235 007
May 06, 2016 $18.38 $19.21 $18.33 $19.21 285 274
May 05, 2016 $18.81 $18.91 $18.32 $18.57 169 098
May 04, 2016 $19.00 $19.17 $18.58 $18.65 208 927
May 03, 2016 $19.68 $19.80 $18.96 $19.11 151 187
May 02, 2016 $18.90 $20.00 $18.58 $19.97 164 895
Apr 29, 2016 $19.12 $19.22 $18.40 $18.83 211 522
Apr 28, 2016 $20.00 $20.15 $19.16 $19.25 180 672
Apr 27, 2016 $20.39 $20.58 $19.22 $20.09 166 393
Apr 26, 2016 $21.06 $21.08 $20.25 $20.46 148 088
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT